A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse
The effective treatment of central nervous system (CNS) disorders such as multiple sclerosis (MS) has been challenging due to the limited ability of therapeutic agents to cross the blood–brain barrier (BBB). In this study, we investigated the potential of nanocarrier systems to deliver miR-155-antag...
Main Authors: | Trideva Sastri Koduru, Vishal N. Gupta, Balamuralidhara Veeranna, Shanmuganathan Seetharaman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1254 |
Similar Items
-
In vivo therapeutic success of MicroRNA-155 antagomir in a mouse model of pulmonary fibrosis induced by bleomycin
by: Xiaoyuan Sun, et al.
Published: (2021-03-01) -
Lichenoid drug eruption induced by teriflunomide
by: Fatima-Zahra Agharbi, et al.
Published: (2023-01-01) -
TERIFLUNOMIDE - A NEW TABLETED DRUG FOR THERAPY OF REMITTING DISSEMINATED SCLEROSIS (REVIEW)
by: E. V. POPOVA, et al.
Published: (2016-12-01) -
Teriflunomide as a therapeutic means for myelin repair
by: Peter Göttle, et al.
Published: (2023-01-01) -
Antidepressant effect of teriflunomide via oligodendrocyte protection in a mouse model
by: Shuting Luo, et al.
Published: (2024-04-01)